Probucol treatment reverses antioxidant and functional deficit in diabetic cardiomyopathy

Molecular and Cellular Biochemistry

Volumn 160-161, Issue , 1996, Pages 283-288

  Kaul, N ^a   Siveski Iliskovic, N ^a   Hill, M ^a   Khaper, N ^a   Seneviratne, C ^a   Singal, P K ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b ST BONIFACE GENERAL HOSPITAL   (Canada)

Author keywords

Catalase; Glutathione peroxidase; Lipid peroxidation; Oxidative stress; Superoxide dismutase

Indexed keywords

ANTILIPEMIC AGENT; ANTIOXIDANT; CATALASE; GLUCOSE; GLUTATHIONE PEROXIDASE; HEART ENZYME; INSULIN; PROBUCOL; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HEART FUNCTION; HEART LEFT VENTRICLE PRESSURE; INSULIN BLOOD LEVEL; INTRAPERITONEAL DRUG ADMINISTRATION; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; STREPTOZOCIN DIABETES; SYSTOLIC BLOOD PRESSURE;

ANIMALS; ANTIOXIDANTS; BODY WEIGHT; CARDIOMYOPATHIES; CATALASE; DIABETES MELLITUS, EXPERIMENTAL; GLUTATHIONE PEROXIDASE; HEMODYNAMIC PROCESSES; LIPID PEROXIDES; MALE; MYOCARDIUM; PROBUCOL; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

ANIMALIA;

EID: 0029791641     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00240060     Document Type: Article

References (43)

1. Kannel WB: Role of diabetes in cardiac disease. In: S. Zoneraich, (ed.) Diabetes and the Heart, Charles C. Thomas, Springfield, Illinois pp 97-120
2. Rubler S, Dlugash J, Yuceoglu UZ, Kumral T, Branwood AW, Grishman A: New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 30: 595-602, 1972
3. Regan TJ, Lyons MM, Ahmed S, Levinson GE, Oldewurtel HA, Ahman M, Haider B: Evidence for cardiomyopathy in familial diabetes mellitus. J Clin Invest 60: 885-893, 1977
4. Dhalla NS, Pierce GN, Innes IR, Beamish RE: Pathogenesis of cardiac dysfunction in diabetes mellitus. Can J Cardiol 1: 263-284, 1985
5. Fein FS, Sonnenblick EH: Diabetic cardiomyopathy. Prog Cardiovasc Dis H 27: 255-270, 1985
6. Wohaieb SA, Godin DV: Alterations in free radical tissue defense mechanisms in streptozotocin induced diabetes in the rat: Effects of insulin treatment. Diabetes 36: 1014-1018, 1987
7. Kaul N, Siveski-Iliskovic N, Thomas TP, Hill M, Khaper N, Singal PK: Probucol improves antioxidant activity and modulates development of diabetic cardiomyopathy. Nutrition. In Press, 1995
8. Simmons KJ Defence against free radicals has therapeutic implications. J Amer Med Assoc 251: 2187-2192, 1984
9. Halliwell G, Gutteridge JMC: Lipid peroxidation, oxygen radicals, cell damage and antioxidant therapy. Lancet I: 1396-1397, 1984
10. Kaul N, Siveski-Iliskovic N, Hill M, Slezak J, Singal PK: Free radicals in the heart. J Pharmacol Toxicol Meth 30: 55-63, 1993
11. Parthasarathy S, Young SG, Witztum TL, Pittman RC, Steinberg D: Probucol inhibits oxidative modification of low density lipoproteins. J Clin Invest 77: 641-644, 1986
12. Carew TE, Schwenke DC, Steinberg D: Antiatherogenic effect of Probucol unrelated to its hypocholesterolemic effect. Proc Natl Acad Sci, USA 84: 7725-7729, 1984
13. Siveski-Iliskovic N, Kaul N, Singal PK: Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy. Circulation. 89: 2829-2835, 1994
14. Siveski-Iliskovic N, Hill M, Chow D, Singal PK: Probucol protects against adriamycin cardiomyopathy without interfering with its antitumor effect. Circulation 91: 10-15, 1995
15. Chisolm GM, Morel DW: Lipoprotein oxidation and cytotoxicity: Effect of probucol on streptozotocin treated rats. Am J Cardiol 62: 20B-26B, 1988
16. Morel DW, Chisolm GM: Antioxidant treatment of diabetic rats inhibits lipoprotein oxidation and cytotoxicity. J Lipid Res 30: 1827-1834, 1989
17. Matsushita M, Yoshino G, Iwai M: Protective effects of probucol on alloxan diabetes in rats. Diabetes Res Clin Prac 7: 313-316, 1989
18. Bondar RJL, Mead DC: Evaluation of glucose-6-phosphate dehydrogenase from leuconostoc mesenterioles in the hexokinase method for determining glucose in serum. Clin Chem 20: 586-590, 1974
19. Marklund SL: Pyrogallol autoxidation. In: R.A. Greenwald, (ed.) Handbook of Methods for Oxygen Radical Research. Boca Raton, Florida: CRC Press, 1985 pp 243-247
20. Paglia DE, Valentine WN: Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70: 158-247, 1967
21. Clairborne A: Catalase activity. In: R.A. Greenwald (ed.) Handbook of Methods for Oxygen Radical Research. Boca Raton, Florida: CRC Press, 1979 pp 283-284
22. Placer ZA, Cushman LL, Johnson BC: Estimation of product of lipid peroxidation (malondialdehyde) in biochemical systems. Anal Biochem 16: 359-365, 1966
23. Aust SD: Lipid peroxidation. In: R.A. Greenwald (ed.) Handbook of Methods for Oxygen Radical. Boca Raton, Florida: CRC Press, 1985 pp 203-207
24. Lowry OH, Rosebrough NJ, Farr AL, Randall AJ: Protein measurement with the folin phenol regent. J Biol Chem 193: 265-275, 1951
25. Regan TJ, Ettinger PO, Khan ME, Jesuani MU, Lyon MM, Oldewurtel HA, Weber M: Altered myocardial function and metabolism in chronic diabetes mellitus without ischemia in dogs. Circ Res 35: 222-237, 1974
26. Factor SM, Minase T, Sonnenblick E: Clinical and morphological features of human hypertensive diabetic cardiomyopathy. Am Heart J 99: 446-458, 1980
27. Heyliger CE, Pierce GN, Singal PK, Beamish RE, Dhalla NS: Cardiac alpha and beta adrenergic receptor alterations in diabetic cardiomyopathy. Basic Res Cardiol 77: 610-618, 1982
28. Pierce GN, Dhalla NS: Mechanism of defect in cardiac myofibrillar function during diabetes. Am J Physiol 248: E170-E175, 1985
29. 2+ binding by and composition of the cardiac sarcolemmal membrane in chronic diabetes. Proc Natl J Acad Sci, USA 80: 5412-5416, 1983
30. Makino N, Dhalla KS, Elimban V, Dhalla NS: Sarcolemmal calcium transport in streptozotocin-induced diabetic cardiomyopathy in rats. Am J Physiol 253: E202-E207, 1983
31. Penparkgul S, Fein F, Sonnenblick Eh, Scheuer J: Depressed cardiac sarcoplasmic reticular function from diabetic rats. J Mol Cell Cardiol 13: 303-309, 1981
32. Ganguly PK, Pierce GN, Dhalla KS, Dhalla NS: Defective sarcoplasmic reticulum calcium transport in diabetic cardiomyopathy. Am J Physiol 244: E528-E535, 1983
33. Kobayashi A, Yamashete T, Kaneko M, Nishiyama T, Hayashi H, Yamazaki N: Effects of verapamil on experimental cardiomyopathy in the Syrian hamster. JACC 10: 1128-1134, 1987
34. Gupta M, Singal PK: Time course of structure, function, and metabolic changes due to an exogenous source of oxygen metabolites in rat heart. Can J Physiol Pharmacol 67: 1549-1559, 1989
35. Guarnieri C, Flamigni F, Caldarera CM: Role of oxygen in cellular damage induced by reoxygenation of hypoxic heart. J Mol Cell Cardiol 12: 797-808, 1980
36. Hodgson EK, Fridovich I: The interaction of bovine erythrocyte Superoxide dismutase with hydrogen peroxide: Chemiluminescence and peroxidation. Biochemistry 14: 5399-5303, 1975
37. Searle AJ, Willson RL: Glutathione peroxide: Effect of superoxide, hydroxyl and bromine free radicals on enzyme activity. Int J Radiat Biol 37: 213-217, 1980
38. Giuliano D, Acampara R, D'Onofrio P: Medical hypothesis: cardiovascular complications of diabetes mellitus-from glucose to insulin and back. Diabetic Metabol 20: 445-453, 1994
39. Marshall RN: Pharmacology and toxicology of probucol. Artery 10: 7-21, 1982
40. Drash AL, Rudert WA, Borquaye S, Wang R, Lieberman I: Effect of probucol on development of diabetes mellitus in BB rats. Am J Cardiol 62: 27B-30B, 1988
41. O'Brien K, Nagano Y, Gown A, Kita T, Chait A: Probucol treatment affects the cellular composition but not antioxidized low density lipoprotein immunoreactivity of plaque from Watanabe heritable hyperlipedimic rabbits. Arteriosclerosis and Thrombosis 11: 751-759, 1991
42. Litwin SE, Raya TE, Anderson PG, Daugherty S, Goldman S: Abnormal cardiac function in the streptozotocin-diabetic rat. J Clin Invest 86: 481-488, 1990
43. Schwartz CJ: Introduction - The Probucol Experience: A review of the past and a look at the future. Am J Cardiol 62: 1B-5B, 1988